Musculoskeletal

Chronic Lower Back Pain (CLBP) market size in 7MM is expected to grow at a CAGR of 4.84% for the study period (2017-2028). The CLBP therapy market although, is entirely dependent on supportive therapies, but the drugs such as opioids and NSAIDs, have also been approved to ease the pain associated with CLBP. The prescription of CLBP drugs varies greatly in 7MM. Use of opioids is more prevalent in the US, whereas the case is same with NSAIDs if we talk about EU5. The chronic lower back pain aetiology, in 80-90% of cases, is a mechanical misbalance in the body, including a degenerative disc or joint disease, vertebral fracture, and deformities, and remaining of chron...